Stanford Cancer Institute Directory
Stanford Cancer Institute Profiles
Showing 181 - 190 of 458
Associate Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center
Dr. Iagaru is an Associate Professor of Radiology - Nuclear Medicine and the Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford Health Care. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine, where he was the chief resident. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University's School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; and radioimmunotherapy. Since joining the faculty at Stanford in 2007, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award; American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009, 2014 and 2015Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; and a Stanford Cancer Center 2009 Developmental Cancer Research Award in Translational Science. Dr. Iagaru presented more than 100 abstracts at national and international meetings and published more than 100 papers in peer-reviewed journals, as well as 7 book chapters.
C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) and, by courtesy, of Statistics and of Biomedical Data Science
C.F. Rehnborg Chair in Disease Prevention at Stanford University, Professor of Medicine, Professor of Health Research and Policy, Professor (by courtesy) of Biomedical Data Science, Professor (by courtesy) of Statistics; co-Director, Meta-Research Innovation Center at Stanford; Director of the PhD program in Epidemiology and Clinical Research. Born in New York City in 1965 and raised in Athens, Greece. Valedictorian (1984) at Athens College; National Award of the Greek Mathematical Society (1984); MD (top rank of medical school class) from the National University of Athens in 1990; also received DSc in biopathology from the same institution. Trained at Harvard and Tufts (internal medicine and infectious diseases), then held positions at NIH, Johns Hopkins and Tufts. Chaired the Department of Hygiene and Epidemiology, University of Ioannina Medical School in 1999-2010 (tenured professor since 2003). Adjunct faculty for Tufts University since 1996 (professor rank since 2002), Director (2008-2010) of the the Center for Genetic Epidemiology and Modeling; also adjunct professor of epidemiology at Harvard School of Public Health and visiting professor of epidemiology and biostatistics at Imperial College. Member of the executive board of the Human Genome Epidemiology Network and Senior Advisor on Knowledge Integration at NCI/NIH (2012-6). Served as President, Society for Research Synthesis Methodology, and editorial board member of many leading journals (including PLoS Medicine, Lancet, Annals of Internal Medicine, JNCI, Science Translational Medicine, Clinical Chemistry, Molecular and Cellular Proteomics, AIDS, IJE, JCE, Clinical Trials, and PLoS ONE, among others) and as Editor-in-Chief of the European Journal of Clinical Investigation (2010-now). Delivered ~500 invited and honorary lectures. Recipient of many awards (e.g. European Award for Excellence in Clinical Science , Medal for Distinguished Service, Teachers College, Columbia University , Chanchlani Global Health Award ). Inducted in the Association of American Physicians (2009), European Academy of Cancer Sciences (2010) American Epidemiological Society (2015), and European Academy of Sciences and Arts (2015). Honorary titles from FORTH (2014) and Ioannina (2015) and honorary doctorates from Rotterdam (2015) and Athens (2017). Multiple honorary lectureships (Caltech, Oxford, LSHTM, Yale, U Utah, UConn among others). The PLoS Medicine paper on “Why most published research findings are false” has been the most-accessed article in the history of Public Library of Science (2.5 million hits). Author of 6 literary books in Greek, two of which (“Toccata for the Girl with the Burnt Face” (Kedros 2012) and “Variations on the Art of the Fugue and a Desperate Ricercar” (Kedros 2014)) were shortlisted for best book of the year Anagnostis awards. Brave Thinker scientist for 2010 according to Atlantic, “may be one of the most influential scientists alive”. Author of ~1000 papers in peer-reviewed journals, 67% of papers as single/first/last author. Highly Cited Researcher according to Thomson Reuters in both Clinical Medicine and in Social Sciences. Citation indices: h=160, m=7 per Google Scholar (h=134 per ISI and Scopus). Current citation rates: >2,500 new citations per month per Google Scholar, >1,300 new citations per month per Scopus or Web of Knowledge. Current citation rates suggest that I am among the 20 scientists worldwide who are currently the most commonly cited, perhaps also the currently most-cited physician. This probably only proves that citation metrics are highly unreliable, since I estimate that I have been rejected over 1,000 times in my life. Regardless, I consider myself privileged to have learned and to continue to learn from interactions with students and young scientists (of all ages) from all over the world and I love to be constantly reminded that I know next to nothing.
Assistant Professor of Chemical and Systems Biology and of Developmental Biology
Daniel Jarosz, Ph.D., is an Assistant Professor in the Departments of Chemical & Systems Biology and Developmental Biology at Stanford University. He received his B.S. in Chemistry and Biochemistry from the University of Washington and then moved to Massachusetts Institute of Technology for his PhD, where he investigated mechanisms of replication and mutagenesis in the laboratory of Dr. Graham Walker. Following his graduation in 2007, Dr. Jarosz pursued postdoctoral training at the Whitehead Institute with Dr. Susan Lindquist, a pioneer in the field of protein folding. In 2013 Dr. Jarosz established his independent group at Stanford University, where his research is focused on molecular mechanisms that contribute to robustness and evolvability. His work employs multidisciplinary systems approaches ranging from chemical biology to quantitative genetics to understand how these mechanisms contribute to evolution, disease, and development. Dr. Jarosz has received a number of distinctions including being named a Searle Scholar and Kimmel Scholar. He has also received a Science and Engineering Fellowship from the David and Lucile Packard Foundation, a Director's New Innovator Award from the NIH, a CAREER award from the NSF, a Pathway to Independence Award from the NIH, and a fellowship from the Damon Runyon Cancer Research Foundation.
John and Marva Warnock Professor
Stefanie Jeffrey, MD, is the John and Marva Warnock Professor and Chief of Surgical Oncology Research in the Department of Surgery at Stanford University School of Medicine. She received her undergraduate degree in Chemistry and Physics and master’s degree in Chemistry from Harvard University. She graduated from medical school at University of California San Francisco (UCSF), where she also completed her surgical residency. Her lab focuses on technology development and applications related to liquid biopsy (CTCs, ctDNA, extracellular vesicles), droplet-based microfluidic platforms, and preclinical models for testing new cancer therapies.